People who are in the business of treating nausea (anesthesiologists, oncologists) have seen in the past electrical wrist devices designed to prevent nausea and vomiting. Even though not highly efficacious, these gadgets could be useful adjuncts for some patients. Chicago-based Neurowave Medical Technologies has released its newest transdermal neuromodulation device, the Nometex. The new device, which resembles a wristwatch, is designed to treat chemotherapy-induced nausea and vomiting without drugs.
According to the company, in a clinical study, treatment with Nometex reduced nausea and vomiting without the side effects commonly associated with existing pharmaceutical treatments.
From the press release:
Nometex was designed to improve the quality of life for the more than 1.2 million Americans who undergo chemotherapy-radiation treatments each year. Its innovative approach to delivering continuous protection against CINV — one of most feared side effects of chemotherapy — garnered enthusiastic professional response at ASCO. Renowned oncologists recognized the clinical efficacy of the drug-free solution, along with its potential to reduce morbidity and cost of therapy.
In a clinical study to test the efficacy of Nometex in gynecologic oncology patients, results showed a significant reduction in the severity of nausea over days 2-4. Further, 92% of active patients using Nometex stated they would recommend the device to others undergoing chemotherapy.
Product page: Nometex™